Carcinogenesisvol.29no.11pp.2139–2146,2008doi:10.1093/carcin/bgn200AdvanceAccesspublicationAugust25,2008YAP1isinvolvedinmesotheliomadevelopmentandnegativelyregulatedbyMerlinthroughphosphorylationToshihikoYokoyama1,HirotakaOsada1,2,HidekiMurakami1,YoshioTatematsu1,TetsuoTaniguchi1,YutakaKondo1,YasushiYatabe3,YoshinoriHasegawa4,KaoruShimokata5,YoshitsuguHorio6,ToyoakiHida6andYoshitakaSekido1,1DivisionofMolecularOncology,AichiCancerCenterResearchInstitute,1-1Kanokoden,Chikusa-ku,Nagoya464-8681,Japan,2DepartmentofCellularOncology,NagoyaUniversityGraduateSchoolofMedicine,65Tsurumai-cho,Showa-ku,Nagoya466-8550,Japan,3DepartmentofPathologyandMolecularDiagnostics,AichiCancerCenterHospital,1-1Kanokoden,Chikusa-ku,Nagoya464-8681,Japan,4DepartmentofRespiratoryMedicine,NagoyaUniversitySchoolofMedicine,65Tsurumai-cho,Showa-ku,Nagoya466-8550,Japan,5DepartmentofBiomedicalSciences,CollegeofLifeandHealthSciences,ChubuUniversity,1200Matsumoto-cho,Kasugai487-8501,Japanand6DepartmentofThoracicOncology,AichiCancerCenterHospital,1-1Kanokoden,Chikusa-ku,Nagoya464-8681,JapanTowhomcorrespondenceshouldbeaddressed.Tel:þ81527642993;Fax:+81527642993;Email:ysekido@aichi-cc.jpWepreviouslyreportedtheresultsofbacterialartiﬁcialchromo-somearraycomprehensivegenomichybridizationofmalignantpleuralmesotheliomas(MPMs),includingtwocaseswithhigh-levelampliﬁcationinthe11q22locus.Inthisstudy,wefoundthattheYAP1geneencodingatranscriptionalcoactivatorwaslocal-izedinthisampliﬁedregionandoverexpressedinbothcases,suggestingitasacandidateoncogeneinthisregion.WeanalyzedtheinvolvementofYAP1inMPMproliferation,aswellasitsfunctionalandphysicalinteractionwithMerlinencodedbytheneuroﬁbromatosistype2(NF2)tumorsuppressorgene,whichisfrequentlymutatedinMPMs.YAP1-RNAinterferencesup-pressedgrowthofamesotheliomacelllineNCI-H290withNF2homozygousdeletion,probablythroughcell-cyclearrestandap-optosisinduction,whereasYAP1transfectionpromotedthegrowthofMeT-5A,animmortalizedmesothelialcellline.WealsofoundthattheintroductionofNF2intoNCI-H290inducedphos-phorylationatserine127ofYAP1,whichwasaccompaniedbyreductionofnuclearlocalizationofYAP1,whereasnuclearlocal-izationofaYAP1S127Amutantwasnotaffected.Furthermore,resultsofimmunoprecipitationandinvitropull-downassaysin-dicatedaphysicalinteractionbetweenMerlinandYAP1.TheseresultssuggestthatYAP1isinvolvedinmesothelialcellgrowthandthatthetranscriptionalcoactivatoractivityofYAP1isfunc-tionallyinhibitedbyMerlinthroughtheinductionofphosphory-lationandcytoplasmicretentionofYAP1.ThisistheﬁrstreportofnegativeregulatorysignalingfromMerlintoYAP1inmamma-liancells.FuturestudiesoftranscriptionaltargetsofYAP1inMPMsmayshedlightonthemolecularmechanismsofMPMdevelopmentandleadtonewtherapeuticstrategies.IntroductionAmalignantpleuralmesothelioma(MPM)isahighlylethalneoplasmthatisthoughttodevelopfrompleuralmesothelialcells,withexpo-suretoasbestosplayingacrucialroleintumordevelopment(1–4).PatientswithanMPMareusuallydiagnosedatanadvancedstageandthetumorsarerefractorytoconventionaltherapeuticmodalities;thus,theirprognosisisverypoor,eventhoughadvancementsinchemo-therapeuticalmodalitiesthatcombinecisplatinandantifolate,suchaspemetrexedorraltitrexed,havebeenmade(5,6).Thelonglatencyperiodbetweenasbestosexposureandtumorappearanceimpliesthatmultiplegeneticchangesarerequiredformalignanttransformationofmesothelialcells(7,8).AccumulatedgeneticstudieshaveidentiﬁedthattumorsuppressorgenesarecrucialforMPMdevelopment,in-cludingfrequentinactivationofp16INK4a/p14ARFat9p21(9–11)andneuroﬁbromatosistype2(NF2)at22q12(12–14).TheNF2geneisresponsibleforNF2syndrome(15)andencodesMerlin(alsoknownasschwannomin),anezrin/radixin/moesinfamilyproteinthathasbeenshowntobeinvolvedincytoskeletaldynamics,growthfactorreceptorsignalingandcelladhesion(16,17).Tofurtherelucidatethealterationsofoncogenesandtumorsuppres-sorgenesresponsibleforMPMdevelopment,wepreviouslycarriedoutbacterialartiﬁcialchromosome(BAC)arraycomprehensivegenomichybridization(CGH)analysesofMPMspecimensfromatotalof22in-dividualsandreportedseveraldistinctchromosomalalterationsinclud-inghighcopyampliﬁcationof11q22(18).Inthepresentstudy,wefoundthattheYAP1gene,whichwasoriginallyclonedasapartnerofYeskinase(19),resideswithinthe11q22ampliﬁcationregionandthatYAP1isinvolvedinmesothelialcellgrowth.Furthermore,wefoundthatYAP1activitymaybenegativelyregulatedviaMerlinsignalinginmesothelialcells.Toourknowledge,thisistheﬁrstknownreportoftheexistenceofnegativeregulatorysignalingfromMerlintoYAP1inmammaliancells,whichmayplayacrucialroleingrowthregulationofmesothelialcellsanddevelopmentofmalignantmesothelioma.MaterialsandmethodsArrayCGHanalysisandquantitativepolymerasechainreactionanalysesofcopynumberandexpressionGenome-widearrayCGHanalysisof22individualMPMsusingmicroarrayswith2304BACandP-1phage-derivedartiﬁcialchromosomeclonescoveringthewholehumangenomeataresolutionofroughly1.3Mbwaspreviouslyreported(18).Todeterminetheprecisecopynumberswithintheampliﬁcation,quantita-tivepolymerasechainreaction(PCR)usingcustomTaqManprobes(AppliedBiosystems,FosterCity,CA)correspondingtothegenomicsequencesofsevengenes(PGR,TRPC6,ANGPTL5,YAP1,BIRC2,MMP13andAB08258)dis-persedwithinthe3MbregionweredesignedandusedtogetherwithTaqManPCRmastermix(AppliedBiosystems)andanABI7500system(AppliedBio-systems),accordingtothemanufacturer’sinstructions.Thecopynumberoftheleucine-richrepeatcontainingthe4Cgene(alsocalledNGL1)localizedat11p12wasusedasacontrol.Toexaminetheexpressionofgeneswithineachampliﬁ-cation,TaqManexpressionprobes(AppliedBiosystems)forANGPTL5,YAP1,BIRC2andBIRC3wereused,andquantiﬁcationwasperformedasabove.ConstructionofRNAinterferencevectorsandexpressionvectorsToconstructRNAinterference(RNAi)vectors,shorthairpin(sh)oligonucleo-tideswereinsertedintoaplasmidcontainingtheU6promoterandapuromy-cin-resistantgene(20).TwosholigonucleotidesweredesignedfortwodifferentsequenceswithintheYAP1openreadingframe(YAP1-sh1,GGCCATGCTGTCCCAGATGAATandYAP1-sh2,GGAGATGGAATGAA-CATAGAAT).Inaddition,controlvectors,YAP1-scr1andgreenﬂuorescentprotein(GFP)-sh,wereconstructedusingoligonucleotideswithscrambledse-quencesforYAP1-sh1(GGCTGCCATTCGCGACATGAAT)andGFPopenreadingframe(GFP-sh,GCAAGCTGACCCTGAAGTTCA).YAP1cDNAwaspurchasedfromOriGene(Rockville,MD)andinsertedintopcDNA(Invitrogen,Carlsbad,CA)andpEGFP-C1(Clontech,MountainView,CA)vec-tors.Thephosphorylation-defectivemutantYAP1wasconstructedbyinvitromutagenesisatcodon127fromserinetoalanine(S127A),asthephosphoryla-tionofserine127wasreportedtoinduceaninteractionbetween14-3-3andcytoplasmicretention(21).NF2cDNAwasampliﬁedwithreversetranscription–PCRandclonedintopcDNA(Invitrogen)andthelentivirusvec-torpLentiLox3.7.TheNa(þ)/H(þ)exchangerregulatoryfactor1(NHERF1)/ezrin/radixin/moesin-bindingphosphoprotein50kDgeneexpressionconstructsAbbreviations:BAC,bacterialartiﬁcialchromosome;CGH,comprehensivegenomichybridization;EGFP,enhancedgreenﬂuorescentprotein;GST,glu-tathioneS-transferase;MPM,malignantpleuralmesothelioma;NF2,neuroﬁ-bromatosistype2;NHERF1,Na(þ)/H(þ)exchangerregulatoryfactor1;PCR,polymerasechainreaction;RNAi,RNAinterference;SDS,sodiumdodecylsulfate;sh,shorthairpin.ÓTheAuthor2008.PublishedbyOxfordUniversityPress.Allrightsreserved.ForPermissions,pleaseemail:journals.permissions@oxfordjournals.org2139werekindlyprovidedbyDrMaria-MagdalenaGeorgescu(UniversityofTexasM.D.AndersonCancerCenter)andDrMarthaC.Nowycky(UniversityofMedicineandDentistryofNewJersey).CellcultureandcolorimetricandﬂowcytometryanalysesAmalignantmesotheliomacellline(NCI-H290),agiftfromDrAdiF.Gazdar(UniversityofTexasSouthwesternMedicalCenter),andanon-malignantme-sothelialcellline(MeT-5A),purchasedfromAmericanTypeCultureCollec-tion(Rockville,MD),wereculturedasdescribedpreviously(18).YAP1-RNAivectorsweretransfectedintoNCI-H290orMeT-5AcellsusingLipofectamine2000(Invitrogen).Forcellproliferationanalysis,transfectedcellsweretreatedwithpuromycinat1lg/mlfor10days,thenstainedusingTetracolorOne(Seikagaku,Tokyo,Japan),afterwhichabsorbancewasdeterminedat450nm.Foranalysisofthecellcycleandsub-G1population,transfectedcellsweretreatedwithpuromycinat1lg/mlfor24h,afterwhichtheculturemediumanddeadcellswereremoved.Residualandviablecellswerefurtherculturedwithoutpuromycinfor24h,thenharvestedandstainedwithpropidiumiodideforﬂowcytometryanalysis,asdescribedpreviously(20).ImmunoblottinganalysisForpreparationofnuclearandcytoplasmicfractions,cellswereincubatedinhypotonicbufferwith0.5%NP-40,thenthenucleiwerepelletedusingabriefcentrifugation,asdescribedpreviously(22).Forimmunoblottinganalysis,afterharvestingthecellswithlysisbuffer,proteinconcentrationwasdeterminedwithaDCProteinassaykit(Bio-Rad,Hercules,CA).Thesameamountsofproteinsampleswereappliedtosodiumdodecylsulfate(SDS)–polyacrylamidegelelectrophoresis,thenelectrotransferredtoImmobilon-Ppolyvinylidenediﬂuor-idemembranes.Eachmembranewasincubatedwithanti-V5-tag(Invitrogen)forV5-taggedNF2,anti-YAP1(CellSignalingandAbnova,Taipei,Taiwan)andanti-S127phospho-YAP1(CellSignaling,Danvers,MA)antibodies,thenvisu-alizedusinganECLdetectionkit(GEHealthcare,AmershamPlace,UK).ImmunoﬂuorescentmicroscopicanalysisNCI-H290cellsweretransfectedwithexpressionvectorsfortheenhancedgreenﬂuorescentprotein(EGFP)-fusedYAP1wild-typeorS127AmutanttogetherwithV5-taggedNF2oranemptyvectorandculturedoncoverglassslides.Thetransfectedcellswerethenﬁxed,permeabilizedandincubatedwithanti-V5andAlexaFluor568-conjugatedanti-mouseantibodiesandexaminedwithaconfocalmicroscope(LSM510,CarlZeissMicroImagingGmbH,Jena,Germany).Immunoprecipitationandinvitropull-downassaysForimmunoprecipitationanalyses,293TcellsweretransfectedwiththeEGFP-fusedwild-typeorS127AmutantYAP1constructstogetherwithV5-taggedNF2oranemptyvector.Immunoprecipitatesoflysatestransfectedwiththeanti-V5antibodyweresubjectedtoSDS–polyacrylamidegelelectrophoresisandimmunoblottingwithvariousantibodies.Forinvitropull-downassays,humanNF2full-lengthcDNAswereinsertedintoapGEX-KGvector(AmershamPharmaciaBiotech,Uppsala,Sweden)toexpressbacterialglutathioneS-transferase(GST)–Merlinfusionprotein.GST–MerlinorGST-aloneproteinswerepuriﬁedfromthetransformedbacteriallysatesbyincubationwithglutathionesepharosebeads(GEHealthcare).TheYAP1proteinexpressedwithaninvitrotranscription/translationsystem(Promega,Madison,WI)orcelllysateof293Ttransfectantswereincubatedwithbeadscontaining3lgofimmobilizedGST-aloneorGST–Merlinfusionproteinsfor3hat4°C,thenwashedfourtimes.ProteinsboundtoGSTproteinswereelutedbyboilinginSDSsamplebuffer,thenseparatedbySDS–poly-acrylamidegelelectrophoresisandimmunoblottedwithvariousantibodies.ResultsPrecisemappingof11q22ampliﬁcationregioninmalignantmesotheliomasWepreviouslyreportedtheresultsofgenome-widearrayCGHanal-ysesofMPMsderivedfrom22individuals,inwhichitwasnotablethattwoprimaryMPMcases(KD1033andKD1041)showedtwodiscreteandsigniﬁcanthigh-levelampliﬁcationsinthechromosome1p32and11q22regions(18).SincewedemonstratedthattheJUNproto-oncogeneresidedinthe1p32ampliﬁcationregion,whoseex-pressionwasshowntobeinducedbyasbestosexposureinratpleuralmesothelialcells(23)andwhoseampliﬁcationwasrecentlydemon-stratedinaggressivesarcomas(24),wespeculatedthatthe11q22ampliﬁcationregionmayalsoharboranimportanttargetgenewhoseoverexpressionisinvolvedinMPMcellgrowth.Toidentifythetargetgene,wepreciselydeterminedtheextentoftheampliﬁedregionsfromthesetwocasesthatwereoverlappedandboundedbyRP11-40B14andRP11-652L13BACprobes,withonlytwoBACprobes(RP11-203C2andRP11-864G5)includedbetweenthem(Figure1A).WithquantitativePCRanalysisusingTaqManprobes,thecopynum-bersofsevengenes(PGR,TRPC6,ANGPTL5,YAP1,BIRC2,MMP13andAB08258)whichdispersedwithinthe3-Mb-longregionwereinvestigated.Asexpected,bothtumorswereshowntocarryhighcopynumbersoftheANGPTL5,YAP1,BIRC2andMMP13genes,whilenogainsweredetectedinTRPC6andAB08258genes,indicatingthattheextentofthecommonampliﬁcationregionwas1Mbinlengthincluding14candidategenes(Figure1B).Inaddition,comparingwitheachgeneampliﬁcationlevelcarefully,bothANGPTL5andYAP1showedabouta2-foldgreaterincreaseincopynumbersthanBIRC2andMMP13inKD1033,whileeachampliﬁcationlevelofthefourgeneswassimilarinKD1041(Figures1Band2C).Thisresultsuggestedthattheampliﬁcationofthecentromerichalfregionin-cludingANGPTL5andYAP1mightbemoreimportantthanthatoftelomericregionincludingtheBIRC2andMMPclusterduringthedevelopmentofthoseMPMs,atleastinKD1033.OverexpressionofYAP1andBIRC2inmalignantmesotheliomasTodeterminewhichgeneresidinginthe1MbampliﬁcationregionwasthemostresponsibleforthedevelopmentoftheseMPMcases,wenextstudiedtheexpressionlevelsofeachgeneusingreal-timereversetranscription–PCRanalysis.Amongthefourgenesinthecentromerichalfampliﬁcationregion,ANGPTL5,YAP1andBIRC2wereoverex-pressedinKD1033,whereasYAP1,BIRC2andBIRC3inKD1041,indicatingthatonlyYAP1andBIRC2,butnotANGPTL5orBIRC3,werecommonlyoverexpressedinthesetumors(Figure2A).TheseresultsstronglysuggestthatthemostprobabletargetgenesinthisampliﬁcationregionareYAP1andBIRC2.Meanwhile,wealsoex-aminedtheexpressionlevelsofseveralMMPclustergenes,butdidnotdetectanyoverexpression,againsuggestingthatampliﬁcationofthetelomerichalfregionwasnotsigniﬁcant(datanotshown).TheimmunohistochemicalstainingresultsalsoclearlydemonstratedtheoverexpressionofYAP1inKD1033(Figure2B,leftpanel),thoughnormalpleuralmesothelialcellsdidnotshowanyYAP1signals(arrowheadsinFigure2B,rightpanel).Next,todeterminewhetherotherMPMsnotshowntohaveclearampliﬁcationinBAC/P-1phagederivedartiﬁcialchromosomearrayCGHanalysismayalsohaveamoreconﬁnedampliﬁcationorde-regulationoftheYAP1andBIRC2genes,weexaminedthecopynumbersaswellasexpressionlevelsofthesegenesusing12addi-tionalprimaryMPMcases(Figure2CandD)and13MPMcelllines(datanotshown).However,ampliﬁcationofthesegenesintheseMPMspecimensandcelllineswasnotdetected,exceptforKD1033andKD1041,norwastheresigniﬁcantupregulationoftheothersobserved(Figure2CandD).TheseresultssuggestthateventhoughsigniﬁcantoverexpressionoftheYAP1andBIRC2genescanoccur,ampliﬁcationofthesegenesisarelativelyinfrequenteventinMPMs.InvolvementofYAP1inmesothelialcellproliferationTodeterminecancer-promotingrolesofthesegenesinmesotheliomacells,weﬁrstfocusedontheYAP1genesinceitspositiverolehasalsobeensuggestedinothermalignancies(25,26).WesynthesizedtwoYAP1-RNAivectors,YAP1-sh1andYAP1-sh2,tosuppressendoge-nousYAP1expression,ascramblecontrolvector,YAP1-scr1,andaGFP-RNAivector,GFP-sh.ThesevectorsweretransfectedintoMPMcelllineNCI-H290cells,andexpressionlevelsofendogenousYAP1proteinwereexamined.BothYAP1-RNAivectorseffectivelyreducedtheexpressionlevelsofYAP1to30and10%,respectively,whereasthecontrolvectors(GFP-shandYAP1-scr1)didnotdemon-strateanysuppression(Figure3A).WethenstudiedtheeffectsofYAP1-RNAioncellproliferationofmesothelioma.BothYAP1-RNAivectorsdemonstratedsigniﬁcantsuppressionofcellproliferation,withYAP1-sh2showingcompleteabolitionofcellproliferation(Figure3B).FlowcytometryanalysisrevealedthatcellstransfectedbyYAP1-sh2showedG1arrestandinductionofasub-G1populationT.Yokoyamaetal.2140andthosebyYAP1-sh1amoderateinductionofthesub-G1population(Figure3CandD).Incontrast,thecontrolvectorsdidnotshowanygrowth-suppressiveeffect.Furthermore,wetransfectedaYAP1expressionvectorintotheimmortalizedmesothelialcelllineMeT-5AtoﬁgureoutwhetherYAP1hasgrowth-promotingactivityinmesothelialcells.YAP1over-expressionmoderatelysupportedcellproliferationinalow-serumconditionof1%fetalcalfserum,whereasitdidnotdemonstrateclearpromotionofcellproliferationintheusualcondition(fetalcalfserum5%)(Figure3E).FunctionalinteractionbetweenYAP1andMerlinSincetheMerlin-encodingNF2geneisfrequentlyalteredinMPMs,andtheMerlin–Hippo–WartspathwayinDrosophilaisknowntonegativelyregulateYorkie,theDrosophilaorthologofYAP1throughitsphosphorylation(27),theresultsshownabovestronglysuggestedthatMerlin,asanupstreammolecule,mayfunctionallyinteractwithandalsosuppressYAP1inhumanmesothelialcells.Inordertoconﬁrmthishypothesis,wecotransfectedtheNF2andYAP1expressionvectorsintoNCI-H290cellscarryingahomozygousde-letionoftheNF2geneandstudiedwhetherexogenousMerlinhasaneffectonthephosphorylationstatusofYAP1usingtheantibodyagainstphosphorylatedserine127(S127)ofYAP1,acriticalphos-phorylationsitethathasbeenindicatedtoinduceinactivationofYAP1astranscriptioncoactivatorthroughtheinductionofcytoplas-micretention(21).Wefoundthatcotransfectionsigniﬁcantlyin-ducedthephosphorylationofYAP1atS127(Figure4A).TofurtherdemonstrateYAP1S127phosphorylationbytheactivatedformofMerlin,wealsosynthesizedlentivirusvectorsforfull-lengthNF2andtruncatedfour-point-one/ezrin/radixin/moesin(FERM)-NF2whichtranslates340aminoacidsoftheaminoterminalandtransfectedintoNCI-H290cells.Asexpected,S127phosphoryla-tionofYAP1wasinducedbyfull-lengthNF2inadose-dependentmanner,butnotwithtruncatedFERM-NF2(Figure4B).Next,wedeterminedwhetherphosphorylationofYAP1proteininduceditscytoplasmiclocalization,resultinginYAP1inactivationasatranscriptionalcoactivator.WetransfectedNCI-H290cellswithEGFP-fusedwild-typeorS127AmutantYAP1,togetherwithNF2oranemptyvector,andstudiedthesubcellularlocalizationusingimmu-noblotting(Figure4C)andimmunoﬂuorescence(Figure4D).Immu-noblottingoffractionatedlysates,alsodepictedasabargraphintheﬁgure,clearlyshowedthatwild-typephospho-YAP1wasscarcelydetectableinthenuclearfractions,whereasthetotalYAP1proteinwaslocalizedinboththenucleusandcytoplasm(Figure4C).Inaddition,thenuclearproportionofmutantYAP1washigherthanthatofwild-typeYAP1(Figure4C).TheseresultssuggestedthatFig.1.Mappingofampliﬁedregionof11q22locusintwoMPMcases.(A)Detailsofarray-CGHresultsof11q22ampliﬁcationintwoMPMcases.ThesignalratiosfromarrayCGHanalysesoftwoprimaryMPMcases(KD1033andKD1041)wereplottedforallBACclonesbasedonchromosomeposition,andtheresultsindicateddiscreteandsigniﬁcantampliﬁcationsatthe11q22region.Ampliﬁcationsinbothcasesweresimilarwithina3-Mb-longregion,whichwasboundedbyRP11-40B14andRP11-652L13,andincludedonlytwoBACprobes(RP11-203C2andRP11-864G5),representedbyopensquaresandcloseddiamonds,respectively.(B)CopynumberanalysesusingquantitativePCRwithTaqManprobes.Genesandregisteredtranscriptswithinthe3-Mb-longregionareshown.Tofurtherdeterminetheboundariesoftheampliﬁedregions,thecopynumbersofsevengenes(PGR,TRPC6,ANGPTL5,YAP1,BIRC2,MMP13andAB08258,indicatedbyboxes)wereinvestigatedusingTaqManprobes.Fourgenes(ANGPTL5,YAP1,BIRC2andMMP13)showedhighcopynumbersinthetwoMPMcases,suggestingthatbothcarriedquitesimilar1-Mb-longampliﬁcations.YAP1isinvolvedinmesotheliomadevelopmentandnegativelyregulatedbyMerlinthroughphosphorylation2141phosphorylationnegativelyregulatesnuclearlocalizationandtran-scriptionalactivityofYAP1protein.AlthoughMerlininducedphos-phorylationofYAP1,thenuclearproportionofwild-typetotalYAP1wasnotsigniﬁcantlyreduced,probablybecauseoftheexistenceofYAP1-alonetransfectants.Next,weperformedimmunoﬂuorescencetofurtherconﬁrmthatthesubcellularlocalizationofYAP1proteinisdependentonphos-phorylationinducedbyMerlin.NCI-H290cellsweretransfectedwithanEGFP-fusedwild-typeorS127AmutantYAP1construct,togetherwithNF2oranemptyvector.Boththewild-typeandmu-tantYAP1proteinswerefoundtobelocalizedinboththenucleiandcytoplasmoftheemptyvector-cotransfectedcells(Figure4D).Incontrast,cotransfectionoftheNF2vectorclearlyreducednuclearlocalizationofthewild-typeYAP1proteins,butnotthemutantYAP1protein.Inaddition,immunohistochemicalstainingofnuclearaccumulationofYAP1intheMPMcasewithYAP1geneampliﬁ-cation(arrowheadsinFigure2B,leftpanel)alsosupportedtheideathatYAP1localizationinnucleiofthetestedcelllineswasnotduetoanartiﬁcialevent.PhysicalinteractionbetweenYAP1andMerlinSincethesetransfectionexperimentsindicatedafunctionalrelation-shipbetweenMerlinandYAP1,wenextstudiedwhetherthesemol-eculesphysicallyinteractwitheachother.WeimmunoprecipitatedMerlinfromthelysatesof293TcellsthatwerecotransfectedwithNF2and/orYAP1expressionvectorsandtheninvestigatedwhetherYAP1couldbecoprecipitatedwithMerlin(Figure5A).TheresultsclearlydemonstratedthecoprecipitationofYAP1withMerlin,indi-catingaphysicalinteractionbetweenthem.Interestingly,theanti-phospho-YAP1antibodydidnotshowanysignals,whiletheS127AmutantYAP1alsointeractedwithMerlinasdidwild-typeYAP1(Figure5A),suggestingthatMerlinmayalsointeractwithunphos-phorylatedYAP1.Fig.2.AlterationsofcopynumberandexpressionofYAP1andBIRC2.(A)ExpressionanalysesoftheANGPTL5,YAP1,BIRC2andBIRC3genesindicatedthatYAP1andBIRC2wereoverexpressedincommoninbothMPMcaseswithampliﬁcation.(B)ImmunohistochemicalstainingofYAP1.ImmunohistochemicalanalysisclearlydemonstratedoverexpressionandnuclearaccumulationofYAP1inKD1033(leftpanel),whereasnormalpleuralmesothelialcellsdidnotshowanyYAP1signals(arrowheads,rightpanel).(C)ExpressionanalysisinprimaryMPMcases.Inanexaminationof14primaryMPMcasesandthenormalmesothelialcelllineMeT-5A,thetwoMPMcasesshowedthegreatestamountofupregulatedexpressionsoftheYAP1andBIRC2geneswithampliﬁcation.(D)CopynumberanalysisofprimaryMPMcases.Inanexaminationof14MPMcasesandthenormalmesothelialcelllineMeT-5A,onlythetwoMPMcasesdemonstratedampliﬁcationoftheYAP1andBIRC2genes.T.Yokoyamaetal.2142TofurtherconﬁrmthephysicalinteractionbetweenYAP1andMerlin,wepreparedGST-aloneorGST—Merlin-boundglutathionebeadsandthenperformedinvitropull-downassays(Figure5B).First,weconductedapull-downassayusinginvitro-translatedYAP1pro-tein;however,noassociationbetweenYAP1andGST–Merlinwasdetected(SupplementaryFigure1),whichsuggestedthatYAP1wasnotdirectlyassociatedwithMerlin.Next,weperformedapull-downassayusingthelysateof293TcellstransfectedwiththeYAP1ex-pressionvector,asweconsideredthatthecelllysatepossiblycon-tainedendogenousmoleculesthatcouldbridgeYAP1andMerlin.Thepull-downassayusingthe293TcelllysateclearlydemonstratedthatYAP1wasassociatedwithGST–Merlin(Figure5B,lane2).Inaddi-tion,wealsostudiedtheeffectsofNHERF1/ezrin/radixin/moesin-bindingphosphoprotein50kDbecauseitwasreportedtobeassoci-atedwithYAP1(28)aswellaswithMerlin(29),andweconsideredthatitmightbridgetheYAP1andMerlinproteins.However,NHERF1seemedunabletoenhancetheYAP1–Merlinassociation,thoughNHERF1boundtoGST–Merlin(Figure5B,lane4).TheseresultsindicatethatYAP1isindirectlyassociatedwithMerlin,prob-ablythroughanendogenousbridgingmoleculeotherthanNHERF1.DiscussionInthepresentstudy,wedemonstratedthattheYAP1geneislocalizedinthehigh-level11q22ampliﬁcationregion,whichwepreviouslyreportedinastudyoftwocaseswithMPMs,andthatYAP1togetherwithBIRC2areoverexpressedinthesetumors.WealsofoundthatupregulationofYAP1inducedmesothelialcellproliferation,whereasitsdownregulationinhibitedthatproliferation.Furthermore,Merlin-dependentphosphorylationinhibitsthenuclearlocalizationofYAP1,whichmightresultininactivationofYAP1transcriptionalactivity.Ampliﬁcationsatthe11q22locushavebeenreportedforseveraldifferenttypesofhumancancer(25,30–33).Ampliﬁcationsatmousechromosome9qA1,thesyntenicregionofhumanchromosome11q22,havealsobeenshowninmousemammaryandlivercancers(25,26).Furthermore,duringpreparationofthepresentmanuscript,MPMcelllinescarryingchromosomalgainatthe11q22locuswerealsoreported(34).Theseﬁndings,togetherwithourpreviousarrayCGHanalysisonmalignantmesotheliomas,suggestedasigniﬁcantrolefor11q22ampliﬁcationincarcinogenesis.Inthepresentstudy,wedemonstratedthat,amongtheseveralcandidateoncogenesatthe11q22ampliﬁcationregion,boththeYAP1andBIRC2geneswerecommonlyoverexpressedinthetwoMPMtissues,suggestingthatYAP1andBIRC2werethemostlikelytargetgenes.WefocusedonYAP1primarilybecausepreviousreportshavesuggesteditsonco-genicactivityofYAP1(25,26).InvitrotransfectionassaythatutilizedknockdownoroverexpressionofYAP1indicatedthatYAP1promotesgrowthofmesotheliallineagecells,andcotransfectionexperimentsstronglysuggestedthatMerlininhibitsthetranscriptionalactivatoractivityofYAP1throughinductionofphosphorylationandinhibitionFig.3.InvolvementofYAP1incellproliferation.(A)KnockdownofendogenousYAP1inMPMcelllineNCI-H290.BothYAP1-RNAivectors,YAP1-sh1andYAP1-sh2,showedeffectivesuppressionofthelevelofYAP1protein,whereasthecontrolvectors,GFP-shandYAP1-scr1,showednoinhibition.(B)InhibitionofNCI-H290proliferationbyYAP1-RNAi.ColorimetricassayresultsdemonstratedthatboththeYAP1-sh1andYAP1-sh2vectorsinducedsigniﬁcantsuppressionofcellproliferation.YAP1-sh2inhibitedproliferationtoagreaterdegreeascomparedwithYAP1-sh1,consistentwiththeRNAieffect.(C)Cell-cyclearrestbyYAP1-RNAi.YAP1-sh2clearlyinducedG1arrestofNCI-H290cells.(D)Inductionofsub-G1populationbyYAP1-RNAi.Thesub-G1populationofNCI-H290cellswasinducedbybothYAP1-RNAivectors,thoughinductionbyYAP1-sh2wasgreater.(E)PromotionofMeT-5AcellproliferationbyYAP1overexpression.AlthoughYAP1overexpressiondidnotshowacleareffectintheusualcondition[fetalcalfserum(FCS)5%],YAP1overexpressionmoderatelypromotedcellproliferationinthelow-serumcondition(FCS1%).YAP1isinvolvedinmesotheliomadevelopmentandnegativelyregulatedbyMerlinthroughphosphorylation2143ofnuclearlocalization.Toourknowledge,thepresentresultsaretheﬁrsttoshowthatYAP1isregulatedbyMerlinthroughinductionofphosphorylation,indicatingthatYAP1isadownstreameffectorofMerlintumorsuppressorsignalinginmammals.OurﬁndingsalsosuggestthatYAP1mayplayacrucialroleinMPMdevelopmentbecauseMerlintumorsuppressorsignalingisfrequentlyalteredinthosetumors.RecentgeneticandbiochemicalanalysesofDrosophilademon-stratedthatcellproliferationandorgansizearenegativelyregulatedbyakinasecascadeofHippoandWarts(alsocalledLats)andthattwomembrane-associatedproteins,MerlinandExpanded,functionup-streamofthiskinasecascade(35).Yorkie,theDrosophilaorthologofYAP1,isacriticaltargetofthegrowth-inhibitoryHippo–Warts/Latskinasecascadeandapotentialoncogenebecauseitsoverexpres-sioninducestissueovergrowthandapoptosisinhibitionthroughthetransactivationofcycEanddiap1expression(27,36).Drosophilarescueexperimentsalsoindicatedevolutionaryconservationofthesignalingcomponents,thatisthemammalianLATS1,MOB1,MST2andYAPgenes,whichareorthologsoftheDrosophilaWarts,Mats,HippoandYorkigenes,respectively.Duringthepreparationofthismanuscript,Zhaoetal.(37)clearlydemonstratedthattheS127phosphorylationofYAP1wascatalyzedbyLATS1andthatYAP1inactivationplayssigniﬁcantrolesincellcontactinhibitionandtissuegrowthregulation.However,thesignalingpathwayfromMerlintoYAP1hasnotbeenclearlydemonstratedinmammaliancells.YAP1hasbeenreportedtobindtoandregulatetheactivitiesofvarioustranscriptionalregulators,includingp73,RUNX2,ERBB4,andseveralTEAdomain/transcriptionenhancerfactor-typetranscrip-tionfactors,andalsoshowntofunctionasanoncogeneinmammals(25,26),possiblythroughanassociationwithRUNX2(38,39)andERBB4(19,40).YAP1isphosphorylatedatS127,leadingtoitsassociationwith14-3-3,whichsequestratesYAP1inthecytoplasmandinhibitsitscoactivatoractivity(21,41).Thepresentresultsdem-onstratedthatMerlininducesphosphorylationofYAP1S127andinhibitsitsnuclearlocalization.Merlin–YAP1signalingisconceiv-able,because,basedonconservedDrosophilasignaling,MerlinmayactivatetheMST2–LATS1kinasecascade,whileitalsoappearstobindtounphosphorylatedYAP1protein.Fig.4.FunctionalinteractionbetweenYAP1andMerlin.(AandB)InductionofYAP1phosphorylationbyMerlin.(A)NF2-nullNCI-H290cellsweretransfectedwithYAP1andNF2expressionvectors.CotransfectionofNF2signiﬁcantlyinducedphosphorylationoftheYAP1S127residue.(B)Eitherfull-lengthortruncatedNF2wasintroducedintoNCI-H290cellswithalentivirus.PhosphorylationofYAP1wasinducedbythefull-lengthNF2lentivirusinadose-dependentmanner,whereasthetruncatedNF2FERMlentivirusdidnothaveanycleareffect.(C)Immunoblottingofcytoplasmicandnuclearfractions.NCI-H290cellsweretransfectedwithwild-type(wt)orphosphorylation-defectiveS127Amutant(mut)YAP1andNF2expressionvectors.Immunoblotsofnuclearandcytoplasmicfractionsoftransfectantsclearlyshowedthatphospho-YAP1wasmainlylocalizedinthecytoplasm,asdetectedbytheanti-S127phospho-YAP1antibody,thoughtotalYAP1waslocalizedinboththenucleusandcytoplasm.Inaddition,thenuclear/cytoplasmicratioofYAP1andphospho-YAP1proteinswasmeasuredwithadensitometerandindicatedwithabargraph,whichclearlydemonstratesthetightcytoplasmicretentionofwild-typephospho-YAP1protein.NosignalsweredetectedinmutantYAP1transfectantswiththeanti-phospho-YAP1antibody(asterisks).Resultsofimmunoblottingwithantibodiesagainsta-tubulinandnuclearlaminB1indicatedthatproperfractionationoccurred.(D)ReductionofYAP1nuclearlocalizationbyNF2.NCI-H290cellsweretransfectedwithexpressionvectorsoftheEGFP-fusedwild-type(wt)orS127Amutant(mut)YAP1,togetherwiththevectorcontrolorV5-taggedNF2.Boththewild-typeandmutantYAP1proteinslocalizeinboththenucleiandcytoplasmofH290cells.CotransfectionofNF2reducednuclearlocalizationofwild-typeYAP1,whereasthelocalizationofmutantYAP1wasnotaffectedbyNF2.Fig.5.PhysicalinteractionbetweenYAP1andMerlin.(A)Immunoprecipitation:293TcellsweretransfectedwithV5-taggedNF2and/orYAP1expressionvectors,thenMerlinwasimmunoprecipitatedwiththeanti-V5antibodyandcoprecipitationwithYAP1wasstudied.Bothwild-typeandS127AmutantYAP1werecoprecipitatedwithMerlin.Theanti-phospho-YAP1antibodydidnotshowanyclearsignals.(B)Invitropull-downassay.Celllysatesof293TcellsweretransfectedwithaYAP1orNHERF1vector,thenincubatedwithGST-aloneorGST—Merlin-boundbeads.Immunoblotsofbead-boundproteins(Bound)andtheinitialcelllysates(Input)areshown.BothYAP1andNHERF1proteinsboundtoGST–Merlin,thoughNHERF1didnotenhancetheassociationofYAP1withGST–Merlin.IntheimmunoblotofboundNHERF1,non-speciﬁcbandsareindicatedbyasterisks.T.Yokoyamaetal.2144YAP1hasalsobeenreportedtopromoteapoptosisthroughanassociationwithp73(21,42,43).Inaddition,arecentreportdemon-stratedthatLATS1wasactivatedbytumorsuppressorRASSF1AtophosphorylateYAP1andpromotenuclearlocalizationoftheYAP1–p73complex,resultinginapoptosisinduction(44).Therefore,YAP1maypromotebothcellgrowthandapoptosis,dependingontheasso-ciatedtranscriptionfactors.Inthiscontext,overexpressionofBIRC2andBIRC3genes,whichcolocalizeat11q22andencodeapoptosisinhibitors,mightbeessentialforexhibitionoftheoncogenicactivityofYAP1incancerswith11q22ampliﬁcation,withourcasesbeingconsistentwiththisidea.TheNF2geneisfrequentlyinactivatedinMPMs,indicatingthatdownregulationofMerlinsignalingisessentialforMPMdevelop-ment.TheantiproliferativeeffectofMerlininNF2-deﬁcientmeso-theliomacellshasbeensuggestedtobeinducedbyrepressingcyclinD1expression(45),attenuatingfocaladhesionkinasephosphoryla-tion(46)orinteractingwithNF2-associatedguanosinetriphosphate-bindingprotein(47).Nf2(þ/ )miceexposedtoasbestosexhibitacceleratedformationofhighlymalignantmesothelialtumors(48,49).Inaddition,inarecentstudy,conditionalknockoutmousemodelsdevelopedbyinactivatingNf2togetherwithp16Ink4a/p19arf,p53orboth,developedmalignantmesotheliomasatahighinci-dence,supportingthenotionthatNf2inactivationisimportantforthepathogenesisofthesetumors(50).OurresultsrevealedthattheYAP1genecanalsobeanactivatingtargetforasubsetofMPMs,whichwascoincidentallyfoundtobeadownstreameffectoroftheMerlincascade.However,thoughYAP1maybeimportantinthesubsetofMPMwith11q22ampliﬁcation,itsrelevanceinthevastmajorityofMPMcasesisunknownatpresent.Therefore,preciseanalysisoftumorsuppressorsignalinginNF2–MST–WARTS/LATS–YAP1isneededtoshedlightonthemolecularmechanismsofMPMdevelopmentingreaterdetail.Preliminaryanalysisofim-munohistochemicalstainingofYAP1revealedoverexpressionandnuclearlocalizationofYAP1inasubsetofMPMcases,indicatingthefrequentinvolvementofYAP1inMPMdevelopment.Neverthe-less,thepresentresultsprovidenewinsightsintogeneticalterationsinMPMsandcluesfordevelopmentofanewmoleculartargettherapyforpatientswiththesetumors.SupplementarymaterialSupplementaryFigure1canbefoundathttp://carcin.oxfordjournals.org/FundingSpecialCoordinationFundforPromotingScienceandTechnologyfromtheMinistryofEducation,Culture,Sports,ScienceandTech-nology(H18-1-3-3-1);Grant-in-AidforScientiﬁcResearchfromJapanSocietyforthePromotionofScience(18390245).AcknowledgementsWethankDrMasashiKondoandDrNoriyasuUsamifortheirhelpfulcom-mentsandspecialencouragement.DrMaria-MagdalenaGeorgescuandDrMarthaC.Nowyckyfortheconstructs,andDrAdiFGazdarforthecellline.ConﬂictofInterestStatement:Nonedeclared.References1.Carbone,M.etal.(2002)Thepathogenesisofmesothelioma.Semin.Oncol.,29,2–17.2.Pass,H.I.etal.(2004)Malignantpleuralmesothelioma.Curr.Probl.Cancer,28,93–174.3.Robinson,B.W.etal.(2005)Advancesinmalignantmesothelioma.N.Engl.J.Med.,353,1591–1603.4.Ramos-Nino,M.E.etal.(2006)Cellularandmolecularparametersofme-sothelioma.J.Cell.Biochem.,98,723–734.5.Vogelzang,N.J.etal.(2003)PhaseIIIstudyofpemetrexedincombinationwithcisplatinversuscisplatinaloneinpatientswithmalignantpleuralmesothelioma.J.Clin.Oncol.,21,2636–2644.6.vanMeerbeeck,J.P.etal.(2005)RandomizedphaseIIIstudyofcisplatinwithorwithoutraltitrexedinpatientswithmalignantpleuralmesotheli-oma:anintergroupstudyoftheEuropeanOrganisationforResearchandTreatmentofCancerLungCancerGroupandtheNationalCancerInstituteofCanada.J.Clin.Oncol.,23,6881–6889.7.Ascoli,V.etal.(2001)DNAcopynumberchangesinfamilialmalignantmesothelioma.CancerGenet.Cytogenet.,127,80–82.8.Sugarbaker,D.J.etal.(2008)Transcriptomesequencingofmalignantpleu-ralmesotheliomatumors.Proc.NatlAcad.Sci.USA,105,3521–3526.9.Ladanyi,M.(2005)ImplicationsofP16/CDKN2Adeletioninpleuralme-sotheliomas.LungCancer,49(suppl.1),S95–S98.10.Musti,M.etal.(2006)Cytogeneticandmoleculargeneticchangesinmalignantmesothelioma.CancerGenet.Cytogenet.,170,9–15.11.Pei,J.etal.(2006)High-resolutionanalysisof9plossinhumancancercellsusingsinglenucleotidepolymorphism-basedmappingarrays.CancerGenet.Cytogenet.,170,65–68.12.Sekido,Y.etal.(1995)Neuroﬁbromatosistype2(NF2)geneissomati-callymutatedinmesotheliomabutnotinlungcancer.CancerRes.,55,1227–1231.13.Bianchi,A.B.etal.(1995)Highfrequencyofinactivatingmutationsintheneuroﬁbromatosistype2gene(NF2)inprimarymalignantmesotheliomas.Proc.NatlAcad.Sci.USA,92,10854–10858.14.Cheng,J.Q.etal.(1999)FrequentmutationsofNF2andalleliclossfromchromosomeband22q12inmalignantmesothelioma:evidenceforatwo-hitmechanismofNF2inactivation.GenesChromosomesCancer,24,238–242.15.Baser,M.E.(2006)Thedistributionofconstitutionalandsomaticmutationsintheneuroﬁbromatosis2gene.Hum.Mutat.,27,297–306.16.Sun,C.X.etal.(2002)Protein4.1tumorsuppressors:gettingaFERMgripongrowthregulation.J.CellSci.,115,3991–4000.17.McClatchey,A.I.etal.(2005)Membraneorganizationandtumorigenesis—theNF2tumorsuppressor,Merlin.GenesDev.,19,2265–2277.18.Taniguchi,T.etal.(2007)Genomicproﬁlingofmalignantpleuralmeso-theliomawitharray-basedcomparativegenomichybridizationshowsfrequentnon-randomchromosomalalterationregionsincludingJUNampliﬁcationon1p32.CancerSci.,98,438–446.19.Komuro,A.etal.(2003)WWdomain-containingproteinYAPassociateswithErbB-4andactsasaco-transcriptionalactivatorforthecarboxyl-terminalfragmentofErbB-4thattranslocatestothenucleus.J.Biol.Chem.,278,33334–33341.20.Osada,H.etal.(2005)ASH1geneisaspeciﬁctherapeutictargetforlungcancerswithneuroendocrinefeatures.CancerRes.,65,10680–10685.21.Basu,S.etal.(2003)AktphosphorylatestheYes-associatedprotein,YAP,toinduceinteractionwith14-3-3andattenuationofp73-mediatedapopto-sis.Mol.Cell,11,11–23.22.Hayashita,Y.etal.(2005)ApolycistronicmicroRNAcluster,miR-17-92,isoverexpressedinhumanlungcancersandenhancescellproliferation.CancerRes.,65,9628–9632.23.Heintz,N.H.etal.(1993)Persistentinductionofc-fosandc-junexpressionbyasbestos.Proc.NatlAcad.Sci.USA,90,3299–3303.24.Mariani,O.etal.(2007)JUNoncogeneampliﬁcationandoverexpressionblockadipocyticdifferentiationinhighlyaggressivesarcomas.CancerCell,11,361–374.25.Zender,L.etal.(2006)Identiﬁcationandvalidationofoncogenesinlivercancerusinganintegrativeoncogenomicapproach.Cell,125,1253–1267.26.Overholtzer,M.etal.(2006)TransformingpropertiesofYAP,acandidateoncogeneonthechromosome11q22amplicon.Proc.NatlAcad.Sci.USA,103,12405–12410.27.Huang,J.etal.(2005)TheHipposignalingpathwaycoordinatelyregulatescellproliferationandapoptosisbyinactivatingYorkie,theDrosophilaHomologofYAP.Cell,122,421–434.28.Mohler,P.J.etal.(1999)Yes-associatedprotein65localizesp62(c-Yes)totheapicalcompartmentofairwayepitheliabyassociationwithEBP50.J.CellBiol.,147,879–890.29.Murthy,A.etal.(1998)NHE-RF,aregulatorycofactorforNa(þ)-Hþexchange,isacommoninteractorformerlinandERM(MERM)proteins.J.Biol.Chem.,273,1273–1276.30.Bissig,H.etal.(1999)Evaluationoftheclonalrelationshipbetweenprimaryandmetastaticrenalcellcarcinomabycomparativegenomichy-bridization.Am.J.Pathol.,155,267–274.31.Imoto,I.etal.(2001)IdentiﬁcationofcIAP1asacandidatetargetgenewithinanampliconat11q22inesophagealsquamouscellcarcinomas.CancerRes.,61,6629–6634.YAP1isinvolvedinmesotheliomadevelopmentandnegativelyregulatedbyMerlinthroughphosphorylation214532.Dai,Z.etal.(2003)AcomprehensivesearchforDNAampliﬁcationinlungcanceridentiﬁesinhibitorsofapoptosiscIAP1andcIAP2ascandidateoncogenes.Hum.Mol.Genet.,12,791–801.33.Baldwin,C.etal.(2005)Multiplemicroalterationsdetectedathighfre-quencyinoralcancer.CancerRes.,65,7561–7567.34.Zanazzi,C.etal.(2007)Geneexpressionproﬁlingandgenecopy-numberchangesinmalignantmesotheliomacelllines.GenesChromosomesCan-cer,46,895–908.35.Hamaratoglu,F.etal.(2006)Thetumour-suppressorgenesNF2/MerlinandExpandedactthroughHipposignallingtoregulatecellproliferationandapoptosis.Nat.CellBiol.,8,27–36.36.Pan,D.(2007)Hipposignalinginorgansizecontrol.GenesDev.,21,886–897.37.Zhao,B.etal.(2007)InactivationofYAPoncoproteinbytheHippopath-wayisinvolvedincellcontactinhibitionandtissuegrowthcontrol.GenesDev.,21,2747–2761.38.Yagi,R.etal.(1999)AWWdomain-containingyes-associatedprotein(YAP)isanoveltranscriptionalco-activator.EMBOJ.,18,2551–2562.39.Vitolo,M.I.etal.(2007)TheRUNX2transcriptionfactorcooperateswiththeYES-associatedprotein,YAP65,topromotecelltransformation.CancerBiol.Ther.,6,856–863.40.Aqeilan,R.I.etal.(2005)WWdomain-containingproteins,WWOXandYAP,competeforinteractionwithErbB-4andmodulateitstranscriptionalfunction.CancerRes.,65,6764–6772.41.Vassilev,A.etal.(2001)TEAD/TEFtranscriptionfactorsutilizetheacti-vationdomainofYAP65,aSrc/Yes-associatedproteinlocalizedinthecytoplasm.GenesDev.,15,1229–1241.42.Strano,S.etal.(2001)PhysicalinteractionwithYes-associatedproteinenhancesp73transcriptionalactivity.J.Biol.Chem.,276,15164–15173.43.Strano,S.etal.(2005)ThetranscriptionalcoactivatorYes-associatedpro-teindrivesp73gene-targetspeciﬁcityinresponsetoDNAdamage.Mol.Cell,18,447–459.44.Matallanas,D.etal.(2007)RASSF1AelicitsapoptosisthroughanMST2pathwaydirectingproapoptotictranscriptionbythep73tumorsuppressorprotein.Mol.Cell,27,962–975.45.Xiao,G.H.etal.(2005)TheNF2tumorsuppressorgeneproduct,merlin,inhibitscellproliferationandcellcycleprogressionbyrepressingcyclinD1expression.Mol.Cell.Biol.,25,2384–2394.46.Poulikakos,P.I.etal.(2006)Re-expressionofthetumorsuppressorNF2/merlininhibitsinvasivenessinmesotheliomacellsandnegativelyregulatesFAK.Oncogene,25,5960–5968.47.Lee,H.etal.(2007)IdentiﬁcationandcharacterizationofputativetumorsuppressorNGB,aGTP-bindingproteinthatinteractswiththeneuroﬁbro-matosis2protein.Mol.Cell.Biol.,27,2103–2119.48.Fleury-Feith,J.etal.(2003)HemizygosityofNf2isassociatedwithin-creasedsusceptibilitytoasbestos-inducedperitonealtumours.Oncogene,22,3799–3805.49.Altomare,D.A.etal.(2005)Amousemodelrecapitulatingmolecularfeaturesofhumanmesothelioma.CancerRes.,65,8090–8095.50.Jongsma,J.etal.(2008)Aconditionalmousemodelformalignantmeso-thelioma.CancerCell,13,261–271.ReceivedApril9,2008;revisedAugust10,2008;acceptedAugust20,2008T.Yokoyamaetal.2146